Abstract:
Disclosed are compounds of formula (I) which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Abstract:
Compounds having the formula (I) are apoptosis promoters. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Abstract:
Compounds having formula I are useful for partially or fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of formula I and methods of inhibiting immune or autoimmune diseases in a mammal.
Abstract:
Methods of reducing the number of platelets in mammals and preventing or treating pro-thrombotic conditions and diseases that are characterized by an excess of, or undesired activation of, platelets using inhibitors of anti apoptotic Bcl-2 family protein members is disclosed.
Abstract:
Compounds which inhibit the activity of anti-apoptotic Mcl-1 protein, compositions containing the compounds and methods of treating diseases during which are expressed the Mcl-1 protein are disclosed.
Abstract:
Compounds having formula (I), or pharmaceutically acceptable salts or prodrugs thereof, wherein A is nitrogen or (II), wherein W is selected from the group consisting of (1) hydrogen and (2) optionally substituted alkyl; A is selected from the group consisting of (1) -S-, (2) -O-, and (3) -N(R )-, wherein R is hydrogen or C1-C6 alkyl; and R and R together are a carbocyclic or a heterocyclic ring, are useful as antibacterial agents.
Abstract translation:具有式(I)化合物或其药学上可接受的盐或前药,其中A 1是氮或(II),其中W选自(1)氢和(2)任选取代的烷基; A 2选自(1)-S-,(2)-O-和(3)-N(R 7) - ,其中R 7是氢或C 1 -C 6 烷基; R 5和R 6一起是碳环或杂环,可用作抗菌剂。
Abstract:
Disclosed are compounds of formula (I) which inhibit the activity of anti-apoptotic BcI -2 or BcI -xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti -aooptotic Bcl-2 protein.
Abstract:
Compounds of formula (I) which inhibit the activity of anti-apoptotic McI-I protein, compositions containing the compounds, and methods of treating diseases involving overexpressed or unregulated McI-I protein are disclosed.
Abstract:
Compounds which inhibit the activity of anti-apoptotic family protein members, compositions containing the compounds and methods of treating diseases during which occur expression one or more than one of an anti?apoptotic family protein member are disclosed.